top of page

Benefits of Annuloplasty

Annuloplasty is considered the gold standard when surgically repairing the mitral valve. The four priniciples that make it effective are:

 Valve shape restoration

 Valve diameter restoration

 Maximal leaflet coaptation

 Prevention of future dilation (stabilization)

Heart hands icon
BKD_2
Open heart surgery

The procedure requires open heart surgery to allow a surgical band to be placed around the annulus to tighten and reshape it, bringing the leaflets into alignment. The band eventually endothelializes into the structure providing stability to the valve and to prevent further dilation of the annulus.

 

The Alfieri Stitch, also known as edge-to-edge mitral valve repair, is another surgical technique in which a suture is placed between the A2 and P2 segments of the mitral valve, essentially tying two leaflets together to reduce regurgitation. The transcatheter edge-to-edge repair technique (TEER) mimics the Alfieri Stitch by clipping leaflets together.

 

TEER Considerations

While regurgitation is reduced, studies have shown that the absence of an annuloplasty ring is associated with higher repair failure.  By only clipping the leaflets, the annulus is left unsupported allowing for future dilation. Another consideration is that edge-to-edge mitral valve repair prevents future treatment options.

​

The CathHELIX system incorporates the principles of annuloplasty into a transcatheter approach.

1

  1. Belluschi I, Buzzatti N, Castiglioni A, Alfieri O, De Bonis M. The Alfieri’s edge-to-edge technique for mitral valve repair: from a historical milestone of cardiac surgery to the origin of the transcatheter era. Mini-invasive Surg 2020;4:58. http://dx.doi.org/10.20517/2574-1225.2020.

Surgical Technique

1

HVR Cardio logo

HVR Cardio Oy

Upseerinkatu 1, Tower 1

02600 Espoo, Finland

HVR Cardio US Inc.

14530 Martin Drive

Suite 100

Eden Prairie, MN 55344

LinkedIn logo

CAUTION: Investigational device. Limited by Federal (United States) law to investigational use only. CathHELIX™ is not commercially available and is intended for investigational use only. Performance specifications and claims are subject to revision pending completion of regulatory approvals. CathHELIX™ is a trademark of HVR Cardio Oy.

 

© 2025 HVR Cardio Oy. All rights reserved.

bottom of page